These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15115003)

  • 1. Genomic torts: a response to Professor Feldman.
    Rich WJ
    Washburn Law J; 2003; 42(3):615-21. PubMed ID: 15115003
    [No Abstract]   [Full Text] [Related]  

  • 2. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 3. Tread carefully . When it comes to physician referrals, a few tips will help you avoid violating antikickback law.
    English J; Bogart SP; McManus MK
    Mark Health Serv; 2007; 27(3):26-30. PubMed ID: 17896639
    [No Abstract]   [Full Text] [Related]  

  • 4. Litigation plays protective role--and is part of the problem.
    Kennett JD
    Mo Med; 2007; 104(1):12-3. PubMed ID: 17410818
    [No Abstract]   [Full Text] [Related]  

  • 5. Causes for concern and causes of action: a comment on "Pushing drugs".
    Brownsword R
    Washburn Law J; 2003; 42(3):601-14. PubMed ID: 15115002
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity for immunizations: tort liability, biodefense, and Bioshield II.
    Mayer L
    Stanford Law Rev; 2007 Apr; 59(6):1753-90. PubMed ID: 17593591
    [No Abstract]   [Full Text] [Related]  

  • 7. The new Restatement (Third) of Torts--shelter from the product liability storm for pharmaceutical companies and medical device manufacturers?
    Wagner MJ; Peterson LL
    Food Drug Law J; 1998; 53(2):225-42. PubMed ID: 10346683
    [No Abstract]   [Full Text] [Related]  

  • 8. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 9. A patient's right of privacy in computerized pharmacy records.
    Mowery G
    Univ Cincinnati Law Rev; 1998; 66(2):697-746. PubMed ID: 16211743
    [No Abstract]   [Full Text] [Related]  

  • 10. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 11. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 12. Section 8(c) of the proposed Restatement (Third) of Torts: is it really what the doctor ordered?
    Winchester JD
    Cornell Law Rev; 1997 Mar; 82(3):644-93. PubMed ID: 10343053
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug marketing from an Office of Inspector General enforcement perspective.
    Foley LA
    Food Drug Law J; 1995; 50(2):309-12. PubMed ID: 10342999
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical profession and the pharmaceuticals: Indian scenario.
    Agrawal S
    Indian Pediatr; 1998 Jul; 35(7):641-5. PubMed ID: 10216673
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationalizing vaccine injury compensation.
    Mello MM
    Bioethics; 2008 Jan; 22(1):32-42. PubMed ID: 18154587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US provides immunity from legal claims related to three Ebola vaccines.
    McCarthy M
    BMJ; 2014 Dec; 349():g7608. PubMed ID: 25499701
    [No Abstract]   [Full Text] [Related]  

  • 17. Informed consent and public health: are they compatible when it comes to vaccines?
    Parmet WE
    J Health Care Law Policy; 2005; 8(1):71-110. PubMed ID: 16538802
    [No Abstract]   [Full Text] [Related]  

  • 18. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statutory remedies for judicial torts: the need for wrongful birth legislation.
    Wilcoxon KD
    Univ Cincinnati Law Rev; 2001; 69(3):1023-53. PubMed ID: 16389682
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.